Osteopore (ASX:OSX) signed a deal with Swiss Stock Exchange-listed holding firm DiethelmKellerSiberHegner (DKSH) to market and sell Osteopore's off-the-shelf orthopedic products in Singapore, according to a Wednesday filing with the Australian bourse.
As per the multi-year deal, DKSH will promote the company's bone loss treatment products in Singapore, the filing said.
The deal comes after receiving market approvals in March.
Osteopore's shares were up almost 3% in recent Wednesday trade.
Price (AUD): $0.04, Change: $+0.001, Percent Change: +2.56%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.